🔎 Trials Near Me

Início › Leucemia Mieloide Aguda › Oregon › Portland

Ensaios clínicos de Leucemia Mieloide Aguda em Portland, OR

25 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Portland e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecrutandoFase 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05564390

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

RecrutandoFase 1
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07548983

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · a 12 mi de distância
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Idades de 18 a 59 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

RecrutandoFase 3
  • Providence Portland Medical Center, Portland
  • Providence Oncology and Hematology Care Clinic Westside, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06852222

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

RecrutandoFase 1
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT03874052

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Idades de 18 a 59 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecrutandoFase 3
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
6 Months – 21 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

RecrutandoFase 2
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06504459

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecrutandoFase 1/2
  • Oregon Health & Science University, Portland
30 Days · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT04065399

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

RecrutandoFase 1/2
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT03471260

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

RecrutandoFase 3
  • US-Portland OR-OHSU, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06652438

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RecrutandoFase 1/2
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecrutandoFase 3
  • Doernbecher Children's Hospital, Portland
29 Days – 21 Years · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05183035

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RecrutandoFase 3
  • Oregon Health & Science University (OHSU) - Knight Cancer Institute, Portland
Idades de 18 a 75 · Todos os sexos · Atualizado em 17 de jul. de 2026 · NCT05429632

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

RecrutandoFase 1
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT04659616

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

RecrutandoFase 2
  • OHSU Knight Cancer Institute, Portland
Idades de 18 a 65 · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT07228273

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

RecrutandoFase 2
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecrutandoEstudo observacional
  • Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

RecrutandoFase 1
  • OHSU Knight Cancer Institute, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06357182

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RecrutandoFase 2/3
  • Oregon Health and Science University, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT04256317

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

RecrutandoFase 1
  • OHSU, Portland
Idades 18 e acima · Todos os sexos · Atualizado em 9 de fev. de 2026 · NCT06950034

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RecrutandoVoluntários saudáveis bem-vindos
  • Oregon Health & Science University, Portland
Idades de 18 a 120 · Todos os sexos · Atualizado em 25 de jul. de 2025 · NCT05237258

Ensaios de Leucemia Mieloide Aguda em outras cidades

Outros estudos em Portland

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.